Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs Absci
Over the past year BIAF returned −91.9% and ABSI returned +176.9%; their daily moves had a correlation of 0.15.
BIAF −91.9% ABSI +176.9%Growth of $1, one year, split-adjusted
| Metric | BIAF | ABSI |
|---|---|---|
| Price | $3.03 | $12.10 |
| Market cap | $1.8M | $2.08B |
| Today | −3.50% | +1.85% |
| 1 month | −53.8% | +12.3% |
| 6 months | −91.9% | +143.2% |
| Year to date | −82.9% | +246.7% |
| 1 year | −91.9% | +175.0% |
| Revenue growth (YoY) | +19.0% | −46.4% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −222.8% | −10443.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 1,330.3× |
| Net cash | $1.8M | $201.0M |
| Dividend yield | — | — |
| Volatility (60d) | 825.7% | 95.6% |
| Short % of float | 11.4% | 31.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).